Literature DB >> 1332692

Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.

C D Byrne1, T W Wang, C N Hales.   

Abstract

Non-esterified fatty acids (NEFAs) and insulin are important factors in the control of lipoprotein secretion, but the mechanism of action is unclear. The present study was undertaken to determine whether insulin and NEFAs modulated hepatic secretion of triacylglycerol and apolipoprotein B (apo-B) by regulation of hepatic intracellular apo-B content. The experiments were performed with the human hepatoblastoma cell line Hep G2, for periods of up to 72 h in the presence and absence of NEFAs and insulin. Higher concentrations of eicosapentanoate (EPA) sustained for 72 h decreased cellular protein content (at 250 microM) or caused cell death (at 750 microM), and this effect was not observed with the other NEFAs studied, whereas 75 microM-EPA did not affect cell viability. Compared with the absence of NEFA, 75 microM-EPA did not alter the intracellular triacylglycerol content, but decreased the intracellular content of apo-B by 47% (P < 0.01) and decreased secreted triacylglycerol and secreted apo-B by 13% (P < 0.05) and 21% (P < 0.01) respectively, after 72 h. However 250 microM-oleate increased the intracellular triacylglycerol by 36% (P < 0.01), intracellular apo-B by 22% (P < 0.05) and secreted triacylglycerol and apo-B by 20-30% (P < 0.05-0.01). Insulin decreased secreted triacylglycerol and apo-B in the presence of each NEFA studied by 20-30%. There was no correlation between the changes in intracellular triacylglycerol and the rate of secretion. However, when the secreted triacylglycerol or apo-B was plotted against intracellular apo-B content a significant correlation was observed (r = 0.89, P < 0.001 for both analyses). Apo-B mRNA levels did not change after 72 h incubation with oleate or EPA. These results demonstrate that EPA can be toxic to hepatocytes and that NEFAs and insulin control secretion of triacylglycerol and apo-B by regulation of the intracellular apo-B concentration, thus controlling assembly of apo-B with triacylglycerol to form lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332692      PMCID: PMC1132085          DOI: 10.1042/bj2880101

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Fatty acid composition of the plasma lipids in Greenland Eskimos.

Authors:  J Dyerberg; H O Bang; N Hjorne
Journal:  Am J Clin Nutr       Date:  1975-09       Impact factor: 7.045

Review 2.  Protein degradation in the endoplasmic reticulum.

Authors:  R D Klausner; R Sitia
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and secretion by HepG2 cells.

Authors:  R Homan; J E Grossman; H J Pownall
Journal:  J Lipid Res       Date:  1991-02       Impact factor: 5.922

5.  Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. Evidence for two functionally distinct pools.

Authors:  R A Davis; R N Thrift; C C Wu; K E Howell
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

6.  Effects of eicosapentaenoic and docosahexaenoic acids on apoprotein B mRNA and secretion of very low density lipoprotein in HepG2 cells.

Authors:  S H Wong; E A Fisher; J B Marsh
Journal:  Arteriosclerosis       Date:  1989 Nov-Dec

7.  Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B.

Authors:  J L Dixon; S Furukawa; H N Ginsberg
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

8.  The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes.

Authors:  M Uusitupa; O Siitonen; K Pyörälä; A Aro; K Hersio; I Penttilä; E Voutilainen
Journal:  Diabetologia       Date:  1985-09       Impact factor: 10.122

9.  Diabetes and cardiovascular disease. The Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

10.  Effects of hormones and pyruvate on the rates of secretion of very-low-density lipoprotein triacylglycerol and cholesterol by rat hepatocytes.

Authors:  C R Pullinger; G F Gibbons
Journal:  Biochim Biophys Acta       Date:  1985-01-09
View more
  11 in total

Review 1.  The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly.

Authors:  G F Gibbons; A M Brown; D Wiggins; R Pease
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

3.  Solubilization and separation of two distinct carnitine acyltransferases from hepatic microsomes: characterization of the malonyl-CoA-sensitive enzyme.

Authors:  N M Broadway; E D Saggerson
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

Review 4.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

5.  Measurement of apolipoprotein B in various cell lines: correlation between intracellular levels and rates of secretion.

Authors:  A Bakillah; Z Zhou; J Luchoomun; M M Hussain
Journal:  Lipids       Date:  1997-10       Impact factor: 1.880

6.  Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids.

Authors:  C D Byrne; N J Wareham; D C Brown; P M Clark; L J Cox; N E Day; C R Palmer; T W Wang; D R Williams; C N Hales
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

7.  Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.

Authors:  Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

8.  Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.

Authors:  G F Lewis; K D Uffelman; L W Szeto; B Weller; G Steiner
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

9.  Quantification in vivo of the effects of different types of dietary fat on the loci of control involved in hepatic triacylglycerol secretion.

Authors:  A M Moir; B S Park; V A Zammit
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

10.  Body fat distribution and its association with cardiovascular risk factors in adolescent Iranian girls.

Authors:  Naghmeh Zahra Mirhosseini; Suzana Shahar; Majid Ghayour-Mobarhan; Mohammad-Reza Parizadeh; Noor Aini Mohd Yusoff; Mohammad-Taghi Shakeri
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.